In the 1940s, medical researchers began using randomized controlled trials to assess the efficacy of health interventions. In RCTs, researchers create randomly assigned treatment and control groups, ...
In the 1940s, medical researchers began using randomized controlled trials to assess the efficacy of health interventions. In RCTs, researchers create randomly assigned treatment and control groups, ...
EULAR - The European Alliance of Associations for Rheumatology - acknowledges the role of diverse real-world data to ...
Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.1 The three experimental arms of INSIGhT (abemaciclib [n = 72], neratinib [n = 80], and CC-115 [n ...
We need more empirical studies about the impact of generative AI on our mental health. I dissect one recent study to show counterintuitive results. An AI Insider scoop.
MAIA’s novel telomere-targeting therapy being evaluated as a third-line treatment for advanced non-small cell lung cancer ...
Prosigna identified a large high-clinical-risk subgroup with minimal chemotherapy benefit, estimated to avert at most two recurrences per 100 patients treated. Enrollment broadened prior assay use by ...
The European Alliance of Associations for Rheumatology – acknowledges the role of diverse real-world data to complement knowledge from randomised controlled trials. Data presented at the 2026 annual ...
Omeros Corporation is initiated at Hold, reflecting balanced risk/reward after YARTEMLEA's encouraging commercial launch for ...
One-time infusion of anzu-cel (anzutresgene autoleucel, IMA203) PRAME cell therapy induced rapid, deep and durable systemic ...
We hope you've had a chance to review the press release we issued after market close in the U.S. today, announcing the positive top-line results of the Phase III ABTECT Maintenance trial. Joining me ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results